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Multi-modality aphasia therapy is as efficacious as constraint induced aphasia therapy 
for chronic aphasia: A phase 1 study 
 
 
Introduction  
Constraint-induced aphasia therapy (CIAT; Pulvermüller et al., 2001) has been shown 
to be efficacious in promoting positive changes in formal tests of language function 
and client perceptions of everyday communication for many individuals with chronic 
aphasia. Since the publication of the CIAT studies, questions have arisen concerning 
the appropriateness of utilizing well-established multi-modality treatments in aphasia 
rehabilitation (Rose, in press). Multi-modal treatments exploit the often-preserved 
drawing, gesture, reading and writing abilities of individuals with aphasia, either as 
compensation techniques when spoken communication fails to be restored, or as direct 
cross-modal facilitation techniques to reestablish language and speech. Multi-
Modality Aphasia Treatment (M-MAT; Attard, Rose & Lanyon, 2013) is one such 
treatment. What remains unclear is the relative efficacy of these two intensive but 
fundamentally different treatment types (CIAT and M-MAT). Such information is 
necessary to minimize unnecessary health care spending. 
 
Aims and hypotheses 
Primary Aim: To compare the efficacy of M-MAT to CIATplus for individuals with 
chronic aphasia. Based on the small amount of available pilot data we hypothesized 
that CIATplus and M-MAT would be equally efficacious in improving picture-naming 
abilities and reducing aphasia severity immediately following treatment and at 1-
month follow-up. The secondary aim was to explore participant variables impacting 
potential differential responsiveness to treatment. The latter aim was exploratory and 
not hypothesis-driven. 
 
Method 
Participants 
Eleven participants were recruited. Inclusion and exclusion criteria included: single 
left hemisphere stroke at least 12 months prior to the study; aphasia without severe 
apraxia of speech, motor speech disorder, or severe limb apraxia; no history of other 
neurological disorder, uncorrected vision or hearing loss, or substance abuse; not 
currently receiving speech-language pathology services; right handed pre-morbidly; 
and English as first and primary language. Demographic details are provided in Table 
1. Five females and six males participated, ranging from 17 to 88 months post onset. 
There were four individuals with mild, six with moderate, and one with severe 
aphasia. 
 
Research design 
We utilized 11 single-subject multiple-baseline designs with a cross over for 
treatment order. Six participants (RW, SS, BH, LV, JP, PK) received M-MAT first 
followed by CIATplus, while five participants (JB, ST, LM, AC, PD) received 
CIATplus first. Intensity of treatment was constant across both treatments: 3.25 hours 
per day/4 days per week/2 weeks + 45 minutes of refreshment breaks each day (32 
hours contact for each treatment type; 64 hours total). One week separated the two 
treatment phases. Assessments were carried out before treatment (pre-treatment 
assessment—see results in Table 2), after the first 2-week treatment block (mid-
assessment), after the second two-week treatment block (post-assessment), and at one-
month and three-months after treatment completion (follow ups). Three separate 
groups of participants undertook the study over a 6-month period (Group 1—5 
participants, Group 2—3 participants, Group 3—3 participants). Group 1 broke into 
two smaller groups (2 and 3 people) for at least 1 treatment hour per day. 
 
Stimuli 
Treatment stimuli were black and white line drawings of nouns and verbs from the 
Object and Action Naming Battery (Druks & Masterson, 2000), the Snodgrass and 
Vanderwart pictures (Snodgrass & Vanderwart, 1980), and the International Picture-
Naming Project (Szekely et al., 2004). Of these items, 80 (40 nouns and 40 verbs) 
were trained in CIATplus and 80  (40 nouns and 40 verbs) in M-MAT, with 20 items 
(10 nouns and 10 verbs) serving as untreated controls. Eight different categories of 
nouns were utilized: four in CIATplus and four in M-MAT. One-, 2-, and 3-place 
(argument) verbs were balanced across the two treatment phases. 
 
Probing 
Probing of the entire corpus took place at each phase: three probes at pre-treatment, 
post CIATplus, and post M-MAT; and one probe at each of the one and three-month 
follow ups. In addition, probing of the target stimuli (160 items) took place at the 
beginning of every second treatment session (80 items were probed on each occasion, 
so that the entire treated set (160 items) was probed twice across each treatment 
phase).  
 
Procedure 
The procedures adopted for this trial replicated those of a recent pilot study (Attard, 
Rose, & Lanyon, 2013). M-MAT is a manualized treatment protocol (Rose & Attard, 
2011) with the primary treatment objective to facilitate spoken naming rather than 
multi-modality communication. Thus, naming is practiced along with the addition of 
gesture, drawing, reading, and written naming cues.  CIATplus was carried out as 
described by Meinzer and colleagues (2005) and focuses on naming without multi-
modal cues. 
 
Data analysis 
Standard case charts were developed for visual analysis of each participant’s probe 
results across all phases of the study. Effect sizes were calculated on naming probe 
scores using Busk and Serlin’s (1992) d and a classification of the magnitude of effect 
size was made with Beeson and Robey’s (2006) suggestions of small (2.6), medium 
(3.9), and large (5.8) effects for aphasia therapy.  
 
Reliability and Treatment Fidelity 
Inter- and intra-rater reliability was investigated on 20% of the video-recorded probe 
data results. A speech-language pathologist not involved in providing the therapy 
reviewed 10% of video-recordings/live sessions (viewed behind a one-way mirror) 
that were randomly selected and indicated whether the treatment protocols were being 
followed.  
 
Results 
Point-to-point inter- and intra-rater reliability results will be available in March 2013. 
Treatment fidelity was reported to be 100% accurate. Figures 1-11 display the 
individual probe results. Tables 2 and 3 show the results of standardized tests, and 
effect sizes for probes across all phases of the study. 
 
Primary outcome measure: Noun and Verb Probes 
As expected with this heterogenous group of participants, variable effect sizes were 
demonstrated across noun and verb probes.  Of a total 44, 31 effect sizes reached 
small (2), medium (9), or large (20) levels. Overall, higher effect sizes were found for 
nouns and for items treated during the first treatment phase, irrespective of the 
treatment type.  
 
Secondary outcome measure: Western Aphasia Battery Aphasia Quotient 
(WAB AQ) 
All participants demonstrated improvement on the WAB AQ on at least one time 
point. A recent Rasch analysis has suggested variable standard error of measurement 
for WAB AQ according to aphasia severity ranging from <2 points (AQs 30-70) to >6 
(AQ <20; AQ >90) (Hula et al., 2010). In this study, we chose a somewhat 
conservative AQ change score of 3 points overall and/or a 1 point change on either the 
fluency or information rating score (Spontaneous Speech section) to reflect treatment 
responsiveness (see bold text Table 2). Using these criteria, all participants responded 
to the treatments.  
A comparison of WAB AQ immediately following M-MAT as compared to 
immediately following CIATplus revealed four participants favored M-MAT (> 2 
point WAB AQ difference between M-MAT and CIATplus) and five participants 
favored CIATplus. Order effects are likely to have played a significant role: seven 
participants achieved greater WAB AQ change scores following the first treatment 
than following the second treatment phase (compared to mid-phase scores). 
 
Discussion 
This well-controlled, phase one study directly compared M-MAT and CIATplus, two 
intensive but fundamentally different treatments with opposing rationales: constraint 
versus multi-modal support. Results suggest they are equally efficacious, though order 
effects may have masked clear differences. Discussion will center upon the participant 
variables associated with the best response to treatment, the need for large-scale 
randomized studies comparing these two treatments, and the likely mechanisms 
underpinning multi-modal treatment response in chronic aphasia. 
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Table 1. Participant Characteristics 
Participant Age Gender Education 
(years)  
Stroke Type/ 
Lesion side 
MPO  Pre WAB 
AQ 
Limb apraxia Apraxia of 
Speech 
Hemiparesis Handedness  
RW 49 F 15 Left ischemic 77 92.8 Absent Absent Right Right  
SS 59 F 16 Left (type na) 25 91.24 Absent Mild None Right  
LV 69 M 15 Left (type na) 34 85.6 None Mild-Moderate None Right  
JP 64 F 13 Left 
hemorrhagic 
22 77.2 Moderate Very Mild Right Right  
BH 39 M 15 Left ischemic 88 63.8 Mild Mild Right Right  
ST 46 M 16 Left SAH 22 61.5 Mild Mild-Moderate Right Right  
AC 64 F 17 Left (type na) 40 57.4 Mild Severe None Right  
JB 53 M 15 Left ischemic 17 56.8 Mild-
Moderate 
Mild-Moderate Right Right  
LM 74 F 15 Left ischemic 79 51.9 Moderate Moderate None Right  
PD 56 M 19 Left ischemic 22 50.6 Moderate Mild Right Right  
PK 66 M 10 Left ischemic 58 36.2 None Moderate-
Severe 
None Right  
Note: MPO: months post-onset; (type na): type not available 
 
 
 
Table 2a. Results of baseline language and cognitive testing, and at immediate post each treatment, and 1 and 3 month follow up points 
(BH, RW, SS) 
Assessment 
BH RW SS 
Pre 
Tx 
Post 
M 
Post 
C+ 
1 
Mo. 
3 
Mo. 
Pre 
Tx 
Post 
M 
Post 
C+ 
1 
Mo. 
3 
Mo. 
Pre 
Tx 
Post 
M 
Post 
C+ 
1 
Mo. 
3 
Mo. 
Western Aphasia Battery—Revised 
(Kertesz, 2007): 
Aphasia Quotient 
Spontaneous Speech: 
            Information Content /10 
           Fluency /10 
Auditory Verbal Comprehension: 
(Total score /10) 
Repetition (Total score /10) 
Naming and Word Finding: 
                            (Total score /10) 
                 Object Naming /60 
                 Word Fluency /20 
 
 
63.8 
 
5 
5 
 
8.3 
6.1 
 
7.5 
49 
8 
 
 
66.2 
 
5 
6 
 
8.0 
7.3 
 
6.8 
44 
12 
 
 
72.3 
 
7 
6 
 
7.6 
7.2 
 
7.2 
49 
11 
 
 
79.7 
 
9 
6 
 
8.85 
7.6 
 
8.4 
53 
16 
 
 
67.1 
 
8 
6 
 
8.05 
7.0 
 
7.1 
42 
15 
 
 
92.8 
 
9 
9 
 
10 
10 
 
8.4 
57 
7 
 
 
91.9 
 
8 
9 
 
9.7 
9.4 
 
9.4 
59 
15 
 
 
96.1 
 
10 
9 
 
10 
9.1 
 
9.1 
58 
13 
 
 
97.6 
 
10 
9 
 
10 
10 
 
9.8 
60 
18 
 
 
96.8 
 
10 
9 
 
10 
10 
 
9.4 
58 
16 
 
 
91.2 
 
10 
9 
 
9.2 
8.6 
 
8.9 
57 
16 
 
 
95.2 
 
10 
9 
 
9.3 
9.3 
 
9.3 
59 
14 
 
 
92.2 
 
10 
9 
 
9.2 
8.6 
 
9.3 
56 
17 
 
 
94.7 
 
10 
9 
 
9.75 
9.3 
 
9.3 
60 
13 
 
 
94.1 
 
10 
9 
 
9.75 
9.2 
 
9.1 
58 
15 
           Sentence Completion /10 
           Responsive Speech /10 
10 
8 
8 
4 
10 
2 
8 
7 
7 
7 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
9 
7 
10 
10 
10 
10 
10 
10 
10 
8 
Boston Naming Test (Goodglass et al., 
2001) /60  
 
21 
 
27 
 
42 
 
38 
 
33 
 
44 
 
59 
 
53 
 
55 
 
57 
 
51 
 
56 
 
53 
 
52 
 
50 
Scenario Test (van der Meulen et al., 
2010) /54  
 
32 
 
41 
 
44 
  
 
54 
 
54 
 
54 
  
 
54 
 
54 
 
53 
  
Communicative Effectiveness Index  
(CETI; Lomas et al., 1989)  /100  
 
79 
 
87 
 
86 
  
 
60 
 
60 
 
73 
  
 
68 
 
NA 
 
78 
  
Stroke and Aphasia Quality Of Life 
Scale (SAQOL; Hilari & Byng, 2001) 
Communication  
Psychosocial  
 
 
 
2.57 
5 
 
 
 
 
3.43 
5 
  
 
 
 
3.14 
3.1 
 
 
 
 
3.71 
3.91 
  
 
 
 
4 
5 
 
 
 
 
4.14 
4.55 
  
Pyramids and Palm Trees (Howard & 
Patterson, 1992) /52 
 
47 
    
 
50 
    
 
51 
    
Coloured Progressive Matrices (Raven, 
Court, & Raven, 1995) /36 
 
35 
    
 
32 
    
 
31 
    
 
Note: Pre Tx = Pre treatment; Post M = Post-M-MAT; Post C+ = Post CIATplus; 1 Mo. = 1 month follow-up; 3 Mo. = 3 month follow-up.  
Bold figures: treatment responsiveness (see text)                                 
 
 
 
 
 
 
 
 
 
 
 
 
Rey-Osterrieth Complex Figure Test (as 
cited in Fastenau et al., 1999)  
                                  Copy/36                      
Recall /36 
 
 
 
 
  
 
  36 
 
29.5 
    
 
 
33 
13 
    
 
 
 
 
35 
 
21 
    
Table 2b. Results of language and cognitive testing at baseline, and at immediate post each treatment, and 1 and 3 month follow up 
points (LV, PK, JP) 
 
Assessment 
LV PK JP 
Pre 
Tx 
Post 
M 
Post 
C+ 
1 
Mo. 
3 
Mo. 
Pre 
Tx 
Post 
M 
Post 
C+ 
1 
Mo. 
3 
Mo. 
Pre 
Tx 
Post 
M 
Post 
C+ 
1 
Mo. 
3 
Mo. 
Western Aphasia Battery—Revised 
(Kertesz, 2007): Aphasia Quotient 
Spontaneous Speech 
            Information Content /10 
           Fluency /10 
Auditory Verbal Comprehension  
(Total /10) 
Repetition                         (Total /10) 
Naming and Word Finding
 
(Total /10) 
                 Object Naming /60 
                 Word Fluency /20 
           Sentence Completion /10 
           Responsive Speech /10 
85.6 
 
10 
9 
 
8.0 
9.3 
 
6.1 
42 
2 
7 
10 
 
87.6 
 
10 
9 
 
9.2 
8.9 
 
6.7 
43 
6 
10 
8 
 
 
88.9 
 
10 
9 
 
8.75 
9.4 
 
7.3 
50 
4 
9 
10 
 
 
89.1 
 
10 
9 
 
8.85 
9.4 
 
7.3 
44 
9 
10 
10 
 
 
 
36.2 
 
3 
4 
 
5.7 
3.2 
 
2.2 
12 
6 
0 
4 
 
 
45.2 
 
5 
4 
 
7.1 
2.7 
 
3.8 
24 
5 
3 
6 
 
 
52.9 
 
7 
4 
 
8.05 
2.8 
 
4.6 
27 
8 
4 
7 
 
 
42.6 
 
5 
4 
 
7.2 
1.2 
 
3.9 
25 
5 
3 
6 
 
 
 
77.2  
 
8 
6 
 
8.7 
9.2 
 
6.7 
46 
5 
8 
8 
 
 
81.1 
 
9 
6 
 
8.85 
9.8 
 
6.9 
46 
7 
8 
8 
 
81.6 
 
9 
6 
 
9 
9.8 
 
7 
42 
9 
10 
9 
 
82.4 
 
9 
6 
 
8.9 
9.8 
 
7.5 
48 
7 
10 
10 
 
 
Boston Naming Test   
(Goodglass et al., 2001) /60 
 
28 
 
40 
 
39 
 
44 
 
 
 
3 
 
5 
 
9 
 
11 
 
 
18 
 
30 
 
32 
 
30 
 
Scenario Test                 
  
 
 
 
 
 
 
 
 
 
Note: Pre Tx = Pre treatment; Post M = Post-M-MAT; Post C+ = Post CIATplus; 1 Mo. = 1 month follow-up; 3 Mo. = 3 month follow-up 
 
 
 
 
 
(van der Meulen et al., 2010) /54 54 54 51 38 38 38 48 45 48  
Communicative Effectiveness Index  
(CETI; Lomas et al., 1989)  /100 
 
93 
 
98 
 
99 
 
na 
 
 
 
32 
 
31 
 
28 
 
31 
 
 
 
29 
 
41 
 
43 
 
na 
 
Stroke and Aphasia Quality Of Life 
Scale (SAQOL; Hilari & Byng, 2001)                                   
Communication                                         
Psychosocial  
 
 
 
4.0 
5.0 
 
 
 
3.43 
4.91 
 
 
 
4.43 
4.91 
  
 
 
 
3.14 
5.0 
 
 
 
2.43 
4.64 
 
 
 
3.14 
4.18 
  
 
 
 
2.57 
2.73 
 
 
 
2.14 
3.18 
 
 
 
2.43 
3.0 
 
 
 
 
 
Pyramids and Palm Trees (Howard & 
Patterson, 1992) /52 
 
48 
    
 
39 
    
 
48 
 
   
Coloured Progressive Matrices 
(Raven, Court, & Raven, 1995)  
                                            Copy /36 
                                           Recall /36 
 
 
33 
18.5 
    
 
 
25 
7 
    
 
 
24 
11 
 
   
Table 2c. Results of baseline language and cognitive testing, and at immediate post each treatment, and 1 and 3 month follow up points 
(JB, ST, LM) 
Assessment 
JB ST LM 
Pre 
Tx 
Post 
C+ 
Post 
M 
1 
Mo. 
3 
Mo. 
Pre 
Tx 
Post 
C+ 
Post 
M 
1 
Mo. 
3 
Mo. 
Pre 
Tx 
Post 
C+ 
Post 
M 
1 
Mo. 
3 
Mo. 
Western Aphasia Battery—Revised 
(Kertesz, 2007): 
Aphasia Quotient 
Spontaneous Speech 
            Information Content /10 
           Fluency /10 
Auditory Verbal Comprehension 
(Total score /10) 
Repetition (Total score /10) 
Naming and Word Finding  
(Total score /10) 
                 Object Naming /60 
                 Word Fluency /20 
 
 
56.8 
 
7 
4 
 
7.5 
5.9 
 
6.0 
42 
6 
 
 
55 
 
5 
4 
 
7.2 
5.7 
 
5.6 
35 
5 
 
 
53.8 
 
5 
4 
 
6.6 
4.8 
 
6.5 
42 
7 
 
 
61.5 
 
7 
5 
 
6.95 
6.3 
 
5.5 
34 
5 
 
 
58.70 
 
7 
5 
 
6.85 
5.9 
 
5.5 
34 
7 
 
 
61.5 
 
6 
4 
 
7.55 
5.8 
 
7.4 
50 
7 
 
 
66 
 
6 
4 
 
8.4 
6.8 
 
7.7 
50 
9 
 
 
63.8 
 
7 
4 
 
7.9 
5.9 
 
7.1 
55 
6 
 
 
60 
 
5 
4 
 
8.1 
5.6 
 
7.3 
51 
4 
 
 
61.9 
 
7 
4 
 
7.25 
5.8 
 
6.9 
48 
7 
 
 
51.9 
 
6 
4 
 
4.8 
4.0 
 
4 
29 
1 
 
 
59.1 
 
8 
4 
 
8.15 
4.6 
 
4.8 
24 
6 
 
 
60.9 
 
8 
4 
 
7.75 
5.8 
 
4.9 
29 
8 
 
 
55.6 
 
8 
4 
 
5.9 
5.1 
 
4.8 
29 
6 
 
 
57.5 
 
7 
4 
 
7.65 
4.6 
 
5.5 
35 
6 
           Sentence Completion /10 
           Responsive Speech /10 
5 
7 
8 
8 
8 
8 
6 
10 
8 
6 
7 
10 
10 
8 
6 
4 
8 
10 
6 
8 
4 
6 
8 
10 
6 
6 
6 
7 
6 
8 
Boston Naming Test  
(Goodglass et al., 2001) /60                                                           
 
7
 
9
 
15
 
11 
 
14 
 
27 
 
40 
 
31 
 
32 
 
38 
 
9 
 
14 
 
7 
 
10 
 
12 
Scenario Test (van der Meulen et al., 
2010) /54  
 
40 
 
38 
 
38 
  
 
42 
 
44 
 
43 
  
 
33 
 
40 
 
44 
  
Communicative Effectiveness Index  
(CETI; Lomas et al., 1989)  /100  
 
42 
 
41 
 
39 
  
 
29 
 
NA 
 
62 
  
 
46 
 
46 
 
52 
  
Stroke and Aphasia Quality Of Life 
Scale (SAQOL; Hilari & Byng, 2001) 
                           Communication  
                                Psychosocial  
 
 
3 
4 
 
 
 
3 
4.36 
  
 
 
2.71 
4.18 
 
 
 
2.14 
3.18 
  
 
 
3.14 
4.45 
 
 
 
2.86 
3.8 
  
Pyramids and Palm Trees (Howard & 
Patterson, 1992) /52 
 
43 
    
 
35 
    
 
46 
    
Coloured Progressive Matrices  
Copy /36 
                                            Recall /36 
 
33 
27.5 
    
 
36 
17 
    
 
?? 
9.5 
    
Note: Pre Tx = Pre treatment; Post M = Post-M-MAT; Post C+ = Post CIATplus; 1 Mo. = 1 month follow-up; 3 Mo. = 3 month follow-up.  
Table 2d. Results of baseline language and cognitive testing, and at immediate post each treatment, and 1 and 3 month follow up points 
(AC, PD) 
Assessment 
AC PD 
Pre Tx Post C+ Post M 1 Mo. 
1
 3 Mo. Pre Tx Post C+ Post M 1 Mo. 3 Mo. 
Western Aphasia Battery—Revised 
(Kertesz, 2007): 
Aphasia Quotient 
Spontaneous Speech 
            Information Content /10 
           Fluency /10 
Auditory Verbal Comprehension 
(Total score /10) 
Repetition (Total score /10) 
Naming and Word Finding  (Total /10) 
            Object Naming /60 
            Word Fluency /20 
           Sentence Completion /10 
           Responsive Speech /10 
 
 
57.4 
 
5 
6 
 
8.1 
4.9 
4.7 
28 
7 
4 
8 
 
 
56.3 
 
5 
5 
 
8.95 
3.4 
5.8 
37 
4 
7 
10 
 
 
56.9 
 
5 
5 
 
7.75 
5.2 
5.5 
38 
3 
7 
7 
 
  
 
 
62.1 
 
7 
6 
 
8.45 
2.8 
6.8 
47 
9 
5 
7 
 
 
50.6 
 
4 
3 
 
7.6 
3.2 
3.2 
20 
2 
6 
4 
 
 
54.2 
 
6 
3 
 
7.3 
7.9 
2.9 
12 
5 
8 
4 
 
 
52.8 
 
5 
4 
 
6.4 
7.7 
3.3 
16 
3 
6 
8 
 
 
51.0 
 
4 
3 
 
6.8 
7.5 
4.2 
25 
3 
10 
4 
 
 
53.3 
 
6 
3 
 
6.45 
7.7 
3.5 
20 
4 
7 
4 
Boston Naming Test  
(Goodglass et al., 2001) /60 
 
10 
 
9 
 
13 
 
 
18 
 
2 
 
4 
 
0 
 
1 
 
0 
Scenario Test  
(van der Meulen et al., 2010) /54 
 
46 
 
47 
 
46 
  
 
30 
 
29 
 
31 
 
 
 
 
Communicative Effectiveness Index   
(CETI; Lomas et al., 1989)  /100 
 
54 
 
60 
 
60 
  
 
31 
 
44 
 
64 
  
Stroke and Aphasia Quality Of Life Scale 
(SAQOL; Hilari & Byng, 2001) 
                                                    
Communication  
                                                         
Psychosocial  
 
 
 
3.43 
4.55 
 
 
 
 
 
 
 
 
3.29 
4.09 
  
 
 
 
2.86 
5 
 
 
 
 
3.86 
4.64 
  
Pyramids and Palm Trees Test (3 Pictures) 
(Howard & Patterson, 1992) /52 
 
50 
    
 
42 
    
Note: Pre Tx = Pre treatment; Post M = Post-M-MAT; Post C+ = Post CIATplus; 1 Mo. = 1 month follow-up; 3 Mo. = 3 month follow-up;        
1 AC was overseas during the 1-month follow-up assessment and so this is a missing data point  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coloured Progressive Matrices (Raven, 
Court, & Raven, 1995)                                     
Copy /36                                                         
Recall /36 
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Table 3: Effect sizes for each treatment phase and at 1-month follow up (M-MAT first treatment for first six participants; CIATPlus first 
treatment for second five participants) 
 
 Pre Treatment to Post M-MAT Post M-MAT to Post CIATPlus Post CIATPlus to 1 month follow 
up 
 Nouns 
 
verbs nouns verbs nouns verbs 
BH 30.6 4.8 8.07 13.28 2.84 -4.04 
RW 27.71 4.01 -0.87 0.29 0.44 0 
SS 4.25 4.58 1.0 2.84 0 -1.0 
LV 15.97 2.13 5.29 5.17 -2.39 -0.29 
JP 28.87 6.35 1.88 9.60 1.06 -0.81 
PK 14.33 8.37 27.13 12.67 -3.5 -1.62 
 Pre Treatment to Post CIATPlus Post CIATPlus to Post M-MAT Post M-MAT to 1 month follow up 
 nouns verbs nouns verbs nouns verbs 
JB 10.97 1.44 0.35 0 -1.75 -1.15 
ST 21.94 4.58 0.17 -0.96 -4.04 -2.89 
PD 5.02 6.13 2.51 2.58 -2.31 -0.22 
LM 5.44 22 7.22 5.67 1.0 -0.40 
AC 1.88 20.21 3.68 11.84 4.04* -0.41* 
Note: * 3 month as one-month not available due to participant extended travel; Bold font indicates effect size larger than comparison 
score in reverse treatment phase 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Comparative Baseline, Treatment and Follow-up Probe Results for RW 
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Figure 2. Comparative Baseline, Treatment and Follow-up Probe Results for SS 
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Figure 3. Comparative Baseline, Treatment and Follow-up Probe Results for LV 
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Figure 4.  Comparative Baseline, Treatment and Follow-up Probe Results for JP 
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Figure 5. Comparative Baseline, Treatment and Follow-up Probe Results for BH 
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Figure 6. Comparative Baseline, Treatment and Follow-up Probe Results for AC 
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Figure 7. Comparative Baseline, Treatment and Follow-up Probe Results for LM 
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Figure 8. Comparative Baseline, Treatment and Follow-up Probe Results for PD 
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Figure 9. Comparative Baseline, Treatment and Follow-up Probe Results for ST 
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Figure 10. Comparative Baseline, Treatment and Follow-up Probe Results for JB 
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Figure 11. Comparative Baseline, Treatment and Follow-up Probe Results for PK 
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